Skip to main content
See every side of every news story
Published loading...Updated

Novartis settles with Henrietta Lacks’ estate over use of her ‘stolen’ cells to advance medicine

Novartis agreed to settle claims of profiting from HeLa cells taken without consent, resolving one of multiple lawsuits addressing historic racial exploitation in biomedical research.

  • This month, Novartis settled a lawsuit with Henrietta Lacks' Estate in federal court in Maryland, with terms undisclosed and the matter resolved outside court.
  • The sampled cells from 1951 at Johns Hopkins Hospital became the first immortalized human cell line scientists could cultivate indefinitely, enabling major medical advances.
  • Other suits continue, with attorneys for the Lacks family saying a 2023 settlement with Thermo Fisher Scientific Inc. was followed by a lawsuit against Ultragenyx in Baltimore federal court.
  • This settlement represents a legal milestone, with HeLa cells underpinning medical advances and raising ethical questions about profit from a racist medical system, as the estate alleges.
  • With other cases still active, Johns Hopkins responded that it never profited from the cell lines while the 2024 complaint sought full profits from Novartis's commercialization, and litigation continues.
Insights by Ground AI

86 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 71% of the sources are Center
71% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

abc News broke the news in United States on Thursday, February 26, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal